FindTrial
Sign In

Development of a Cognitive Retraining module called Individualized Cognitive Augmentation Regimen for Elderly (iCARE) with mild to moderate dementia

Development of an Individualized Cognitive Augmentation Regimen for Elderly (iCARE) in mild to moderate dementia: A feasibility study - iCARE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046281
Enrollment
32
Registered
2022-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F03- Unspecified dementia

Interventions

Intervention1: iCARE: iCARE (Individualized Cognitive Augmentation Regimen for Elderly) is a caregiver administered booklet given with materials for 5 weeks with 30 mins-60 min sessions to be conduct

Sponsors

Aparna Kanmani S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient Criteria: 1) Male or female participants 2) Above the age of 55 years 3) Screened through psychiatric / Telepsychiatric consultation from NIMHANS and Diagnosed with Mild-Moderate dementia (DSM V criteria for Major Neurocognitive Disorder) 4) Clinical Dementia Rating, CDR score between 1 and 2 5) Individuals who can attend the session for at least 15-20 minutes 6) Ability to comprehend at least one of the following languages - English, Tamil, Kannada, and Hindi. Caregiver Criteria: 1) Male or female caregiver (family or professional) 2) Has been the primary caregiver for at least 3 months 3) Above the age of 18 years 4) Educated at least till 10th standard 5) Has access to and knowledge of at least one digital device 6) Ability to comprehend at least one of the following languages - English, Tamil, Kannada, and Hindi

Exclusion criteria

Exclusion criteria: 1) History of any major neurological, neurosurgical and/or psychiatric illness other than major neuro cognitive disorder (DSM V) 2) Clinical evidence of mental retardation (MR) in patient 3) Patients with severe sensorimotor/language deficits indicating them not amenable for testing 4) Individuals currently receiving any form of cognitive/psychological interventions

Design outcomes

Primary

MeasureTime frame
Neuropsychological functionsTimepoint: Baseline and 5 weeks—

Secondary

MeasureTime frame
Activities of daily lifeTimepoint: Pre- and post- intervention;Behavioural and psychological symptomsTimepoint: Pre- and post- intervention;Caregiver burdenTimepoint: Pre- and post- intervention;Caregiver HealthTimepoint: Pre- and post- intervention;Cognitive symptomsTimepoint: Pre- and post- intervention, 1-month follow-up;Depressive symptomsTimepoint: Pre- and post- intervention;Feasibility outcome measureTimepoint: Post- intervention;Quality of lifeTimepoint: Pre- and post- intervention—

Countries

India

Contacts

Public ContactAparna Kanmani S

NIMHANS

keshavjkapp@gmail.com08026995190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026